Filing Details
- Accession Number:
- 0001209191-11-033906
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-06-09 18:07:38
- Reporting Period:
- 2011-06-07
- Filing Date:
- 2011-06-09
- Accepted Time:
- 2011-06-09 17:07:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1003642 | Impax Laboratories Inc | IPXL | Pharmaceutical Preparations (2834) | 650403311 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1238456 | R Peter Terreri | C/O Impax Laboratories, Inc. 30831 Huntwood Avenue Hayward CA 94544 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-06-07 | 2,800 | $23.21 | 22,767 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- These shares of common stock were sold by the reporting person to fund the payment of personal income tax obligations arising from the vesting of previously granted restricted stock awards.
- The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $23.20 to $23.22 in multiple transactions. The reporting person undertakes to provide to Impax Laboratories, Inc., any security holder of Impax Laboratories, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Billionaire Hedge Funds
